Skip to content

Advertisement

BMC Complementary and Alternative Medicine

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation

  • A. Kleespies1Email author,
  • M. Mikhailov1,
  • P. N. Khalil1,
  • S. Pratschke1,
  • A. Khandoga1,
  • M. Stangl1,
  • W. D. Illner1,
  • M. K. Angele1,
  • K. W. Jauch1,
  • M. Guba1,
  • J. Werner1 and
  • M. Rentsch1
Contributed equally
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201717:440

https://doi.org/10.1186/s12906-017-1944-4

Received: 15 August 2017

Accepted: 21 August 2017

Published: 4 September 2017

The Correction to this article has been published in BMC Complementary and Alternative Medicine 2017 17:478

Abstract

Background

Approximately 11% of the German population are convinced that certain moon phases and moon signs may impact their health and the onset and clinical course of diseases. Before elective surgery, a considerable number of patients look to optimize the timing of the procedure based on the lunar cycle. Especially patients awaiting living donor kidney transplantation (LDKT) commonly look for an adjustment of the date of transplantation according to the moon calendar. This study therefore investigated the perioperative and long-term outcome of LDKT dependent on moon phases and zodiac signs.

Methods

Patient data were prospectively collected in a continuously updated kidney transplant database. Two hundred and seventy-eight consecutive patients who underwent LDKT between 1994 and December 2009 were selected for the study and retrospectively assigned to the four moon phases (new-moon, waxing-moon, full-moon, and waning-moon) and the corresponding zodiac sign (moon sign Libra), based on the date of transplantation. Preexisting comorbidities, perioperative mortality, surgical outcome, and long-term survival data were analyzed.

Results

Of all LDKT procedures, 11.9, 39.9, 11.5, and 36.5% were performed during the new, waxing, full, and waning moon, respectively, and 6.2% during the moon sign Libra, which is believed to interfere with renal surgery. Survival rates at 1, 5, and 10 years after transplantation were 98.9, 92, and 88.7% (patient survival) and 97.4, 91.6, and 80.6% (graft survival) without any differences between all groups of lunar phases and moon signs. Overall perioperative complications and early graft loss occurred in 21.2 and 1.4%, without statistical difference (p > 0.05) between groups.

Conclusion

Moon phases and the moon sign Libra had no impact on early and long-term outcome measures following LDKT in our study. Thus, concerns of patients awaiting LDKT regarding the ideal time of surgery can be allayed, and surgery may be scheduled independently of the lunar phases.

Keywords

Moon phasesMoon signLiving donor kidney transplantationSurvivalPerioperative morbidity

Background

In comparison to deceased donor transplantation, living donor kidney transplantation (LDKT) provides better patient and allograft survival. Reasons for this are shorter cold ischemic times, reduced time on the waiting list, and the opportunity for patient conditioning as well as to electively schedule surgery [1, 2]. Moreover, the decision to donate and to accept an organ can improve the well-being of both donor and recipient [36]. Nevertheless, the LDKT procedure itself can cause considerable emotional stress for the donor and the recipient. Since the German transplantation law does not permit altruistic organ donation, both donor and recipient frequently have a strong emotional connection (friends or relatives). Therefore, a positive outcome of the LDKT is generally expected and complications are considered unacceptable. However, between 6 and 25% of the complications following LDKT may be due to anatomical conditions (in particular vascular anatomy), AB0 incompatibility, and the recipient’s nutritional status [7]. As a consequence, it is not uncommon that donors and recipients wish to reduce the risk of an adverse outcome by selecting the best date for the transplantation procedure [46, 811]. In particular, patients and their relatives sometimes set the date by following superstition-based predictions. This includes the popular superstition that moon phases (new-, waxing-, full and waning moon) and moon signs (zodiac signs of the moon, which are believed to be associated with a certain part of the human body) might impact outcome after surgery. According to medical astrology, surgical interventions performed during full moon and moon signs of the corresponding surgical region might have a less favorable outcome (Fig. 1, [12]). So far, the timing of living donor kidney transplantation according to the lunar cycle and moon signs has not been investigated. The present work is the first to provide a structured analysis of the clinical impact of timing of an LDKT procedure according to moon phases and the moon sign Libra. The Results of this study might help surgeons to relieve patients’ concerns about the wrong timing of surgery.
Fig. 1

Anatomical-astrological human (drawing by © Alla Mikhailova). According to medical astrology, each organ (or organ system) is associated with a certain moon sign. Note, that the kidneys are assigned to the sign of Libra

Methods

Patients

Between 1994 and 2009, a total of 3722 kidney transplantations were performed at our transplant center. Among those, 278 consecutive pairs of adult living kidney donors and recipients with prospectively registered perioperative data, including the donor and recipient profiles, were evaluated without any exclusions. Among donor surgeries, not more than three complications, requiring surgical (n = 1) or radiologic (n = 2) intervention without relation to moon phases were identified. As a consequence, no reliable conclusion could be drawn by the analysis of the live kidney donors in our cohort. Therefore the donors were not included in further analyses. The recipients’ age varied between 17 and 73 years with exception of three paediatric patients who were 7, 9, and 14 years old at the time of transplantation.

Transplantation legislation

All transplantations were performed in accordance with the legislation of Eurotransplant and Germany. The medical eligibility of donors and recipients was evaluated by primary care physicians and nephrologists. Patients’ registration flowcharts were reviewed by an interdisciplinary review board of our institution and by an independent psychologic review board before transplantation. The study was approved by the local committee of ethics (grant no. 17–151).

Surgical technique and data assessment

Surgical procedures were standardized as previously described [13, 14]. In the case of chronic graft failure, the graft was left in situ unless graft-related complications occurred. At our center, the prospective recording of a recipient’s data starts at the time of Eurotransplant waiting list registration. Data are updated every 6 months. Additional information about the clinical post-transplant course not included in the database was obtained in a 3-step process: information was extracted from the institution’s electronic patient files, checked, and then double checked by independent coworkers. All patient- and clinical data were recorded prospectively; moon phases and moon signs were assigned retrospectively to the date of KT. The following study provides consistent information over a minimum of 3-years of follow-up post transplantation, although all patients were registered for longer than 5 years (i.e. in the context of their first transplantation). Analyses were carried out in complete agreement with GCP guidelines for retrospective analyses [15] and, as far as applicable, according to the suggestions of the ISPOR Task Force on Retrospective Databases for the critical assessment of retrospective analyses [16].

Timing of surgery, moon phases and zodiac signs

The majority of the transplant procedures had been planned irrespective of the moon cycle and moon signs. All surgeries were performed electively without exception. Therefore, all dates of LDKT were retrospectively assigned to the corresponding dates of the four lunar phases (Fig. 2). Lunar phases were defined as follows: the period of the new moon was considered to be ±1 day around the precise day of the new moon, so the entire new moon phase occupied 3 days. The full moon phase was defined similarly. The time interval between the new moon phase and the full moon phase was defined as the waxing moon phase and the time interval between the full moon phase and the new moon phase as the waning moon phase. Since a lunar month (synodic month) lasts about 29.53 days, the phases of waxing moon and of waning moon last approximately 12 days and therefore 4-times longer than the phases of full moon and new moon (3 days). Moon signs were defined as the signs of the Zodiac in which the moon was at the time of the operation. Lunar phases and moon signs for each date of transplantation were acquired from StarDate Online (online service of the University of Texas McDonald Observatory) [17]. According to medical astrology, the moon sign Libra is considered critical for renal and urogenital surgery (Fig. 1). Therefore, we additionally divided the patient cohort into two groups: those who underwent LDKT during the moon sign Libra, and those who did not.
Fig. 2

Moon phases as seen looking southwards from the northern hemisphere (upper part of the diagram not to scale, as the Earth-Moon distance is much bigger than shown here; © Orion 8/Wikimedia Commons/CC-BY-SA-3.0)

Immunosuppressive regimen

Graft recipients were treated with cyclosporine A (3 mg/kg) and prednisolone (250 mg). In addition, immunosuppression included azathioprine (2 mg/kg) or mycophenolate mofetil (MMF, 3 × 1,000 mg/d). Anti-thymocyte globuline (ATG-Fresenius®, 4 mg/kg) was administered as an induction regimen. Patients with re-transplantations were considered to be at a higher immunological risk and received tacrolimus (initial dose: 0.01 mg/kg) and 20 mg basiliximab plus ATG (1 mg/kg) as an induction regimen unless the preformed antibody ratio (PRA) was below 20%, according to the centers immunosuppressive protocol. Cytomegalovirus (CMV) prophylaxis was administered in all patients unless both the donor and the recipient were known to have a CMV-negative serologic status.

Outcome measures definition

The following data were collected for each patient with regard to the date of transplantation: age, gender, total duration of dialysis, duration of the surgical procedure, postoperative morbidity and mortality, graft function (serum creatinine levels), rejection episodes, length of hospital stay, long-term complications, graft and patient survival rates, and causes of graft failure and/or patient death. Acute rejections were biopsy-proven and classified according to the BANFF ‘07 classification [18]. For statistical analysis, only rejections grade 3 and 4 (IA, B and IIA, B) were taken into account. Delayed graft function was defined as need for dialysis, or the absence of a spontaneous drop in serum creatinine within 7 days of transplantation after ruling out accelerated rejection, vascular complications, or urinary tract obstruction [19].

Postoperative morbidity was defined as any postoperative surgical or general complication following transplantation. Postoperative surgical complications such as vascular complications, ureteral complications, events of graft rupture and dislocation, development of lymphoceles, peritonitis, postoperative hemorrhage, events of wound dehiscence, as well as superficial and deep wound infection were recorded as described previously [20, 21]. In addition, the following types of general complications were registered: cardiac events, respiratory events, urinary tract infection, gastrointestinal bleeding and multi-organ failure.

Statistical analysis

Continuous variables are presented as median (range), and categorical variables as total number (percentage). The Kruskal-Wallis- or the Mann–Whitney-U test were used for all comparisons among continuous variables. Categorical variables were compared by Pearson’s Chi-square statistics or Fisher’s exact test for small sample sizes. A p-value of 0.05 or less in a two-tailed test was considered statistically significant. Survival was analyzed using Kaplan-Meier estimates, and survival rates were analyzed using the log-rank test. All statistical analyses were performed using a SPSS Package (PASW version 17.0, SPSS Inc. U.S.A).

Results

Moon phases and moon signs

Thirty-three LDKT (11.9%) were performed during the new moon, 111 (39.9%) during the waning moon, 32 (11.5%) during the full moon, and 102 (36.7%) during the waxing moon. Therefore, all transplant procedures were distributed homogeneously among the main moon phases: new moon + waxing moon with 51.8% and full moon + waning moon with 48.2%. Seventeen of 273 transplantations (6.2%) were performed during the moon sign Libra.

Demographics and medical history

Demographics and preoperative clinical data of all patients are shown in Table 1. Of the 278 patients, 192 (69.1%) were male and 86 (30.9%) were female. The median age and the median body mass index of all recipients were 42 years and 23.8 kg/m2, respectively. The median total duration of dialysis prior to LDKT was 1.96 years, and 30 patients (10.8%) underwent peritoneal dialysis before. Main causes of terminal kidney failure prior to transplantation were chronic glomerulonephritis (n = 88, 31.7%), IgA nephritis (n = 24, 8.6%), polycystic kidney disease (n = 19, 6.8%), and diabetic nephropathy (n = 13, 4.7%). Thirty-three patients (11.9%) had more than one kidney transplantation prior to LDKT. All patients were clinically followed up for a median duration of 8.2 years after LDKT. No differences were seen between all groups of lunar phases and the group of the moon sign libra, with respect to patient’s demographics, underlying kidney disease, medical- and transplant history (Table 1).
Table 1

Demographics and medical history of LDKT recipients

  

Patient groups according to moon phases/moon sign Libra

  

P-value*

 

n (%) a

New moon

Waxing moon

Full moon

Waning moon

Moon sign Libra

 

Demographics

 Number of patients

278 (100.0)

33 (100.0)

111 (100.0)

32 (100.0)

102 (100.0)

17 (100.0)

 

 Age (years) b,c

42.0 [7.4 - 74.0]

45.3 [7.6 - 68.8]

40.0 [17.8 - 73.9]

42.1 [7.4 - 69.0]

45.6 [9.3 - 70.3]

35.9 [23.1 - 61.6]

0.213

 Sex (m/f)

192 (69.0)/86 (31.0)

28 (84.8)/5 (15.2)

74 (66.7)/37 (33.3)

23 (71.9)/9 (28.1)

67 (65.7)/35 (34.3)

12 (70.6)/5 (29.4)

0.186

 BMI (kg/m2) c

23.8 [16.4 - 34.8]

24.5 [16.7 - 30.9]

23.9 [16.4 - 33.8]

22.9 [17.2 - 30.9]

23.8 [16.9 - 34.8]

23.9 [17.4 - 28.0]

0.784

Medical history

 Total duration of dialysis (years) b,c

1.96 [0.04 - 10.64]

1.75 [0.04 - 7.32]

2.02 [0.2 - 10.6]

1.8 [0.2 - 7.7]

2.3 [0.04 - 10.5]

2.4 [0.7 - 10.6]

0.606

 Peritoneal dialysis

30 (10.8)

0 (0)

14 (12.6)

3 (9.4)

13 (12.7)

3 (17.6)

0.176

Cause of kidney failure d

 Chronic glomerulonephritis

88 (31.7)

8 (24.2)

32 (28.8)

11 (34.4)

37 (36.3)

6 (35.3)

0.500

 IgA nephritis

24 (8.6)

4 (12.1)

10 (9.0)

2 (6.3)

8 (7.8)

0 (0)

0.840

 Polycystic kidney disease

19 (6.8)

2 (6.1)

8 (7.2)

2 (6.3)

7 (6.9)

3 (17.6)

0.995

 Diabetic nephropathy

13 (4.7)

2 (6.1)

8 (7.2)

1 (3.1)

2 (2.0)

2 (11.8)

0.308

Transplantation history

 one or more KT prior to LDKT

33 (11.9)

3 (9.09)

14 (12.6)

3 (9.4)

13 (12.7)

2 (11.8)

0.915

Follow up

Follow-up after LDKT (years) c

8.2 [0.13 - 15.2]

8.1 [1.9 - 12.6]

7.9 [0.13 - 14.6]

10.4 [0.8 - 15.2]

8.3 [0.6 - 14.2]

6.0 [1.9 - 12.3]

 

KT kidney transplantation

LDKT living donor kidney transplantation

* p-values are calculated for moon phases only

avalues are number (percentage) unless indicated otherwise

bdata are presented with respect to the date of LDKT

cvalues are median [range]

dmost common causes

Postoperative course

Operative data and the clinical course of patients are shown in Table 2. No significant differences between all groups were found regarding duration of the procedure, postoperative length of stay, postoperative morbidity, rejection episodes, graft loss and 90-day-mortality. Overall, 59 patients (21.2%) developed postoperative surgical complications, and 26 patients (9.4%) demonstrated delayed graft function without significant differences across the study groups; early graft loss (<30 days after transplantation) occurred in four patients (1.4%). With regard to the date of LDKT, patient and graft survival rates at 1, 5, and 10 years were 98.9, 92, and 88.7%, and 97.4, 91.6, and 80.6%, respectively (Fig. 3). The timing of surgery with respect to the moon phases and the moon sign Libra showed no significant impact on long-term patient and graft survival (Figs. 4 and 5). Taken together, we cannot demonstrate any influence of moon phases and the moon sign Libra on the peri- and postoperative course of LDKT patients. In contrast to graft recipients, live donors revealed postoperative complications which required surgical or radiological revision in only 1.1% without relation to moon phases or Libra sign.
Table 2

Operative data and postoperative complications of LDKT recipients

  

Patient groups according to moon phases/moon sign Libra

  

P-value*

 

n (%) a

New moon

Waxing moon

Full moon

Waning moon

Moon sign Libra

 

Number of patients

278 (100.0)

33 (100.0)

111 (100.0)

32 (100.0)

102 (100.0)

17 (100.0)

 

Duration of operation (min.) b

160 [65–345]

155 [120–345]

160 [90–280]

155 [65–295]

160 [99–335]

160 [120–265]

0.532

Graft placement c:

 R-L

133 (47.8)

16 (48.4)

58 (52.3)

17 (53.1)

42 (41.2)

11 (64.7)

0.358

 L-R

91 (32.7)

13 (39.4)

32 (28.8)

9 (28.1)

37 (36.3)

4 (23.5)

0.530

 L-L

23 (8.3)

3 (9.1)

8 (7.2)

2 (6.3)

10 (9.8)

1 (5.9)

0.883

 R-R

31 (11.2)

2 (6.1)

12 (10.8)

4 (12.5)

13 (12.7)

1 (5.9)

0.756

Hospital length of stay (days) b

18 [1–65]

20 [7–43]

17.5 [5–65]

16.5 [7–58]

18 [1–53]

21 [6–32]

0.851

General complications during inhospital stay d,e

12 (4.3)

1 (3.0)

4 (3.6)

2 (6.3)

5 (4.9)

0 (0)

0.887

Surgical complications during inhospital stay f

59 (21.2)

10 (30.3)

23 (20.7)

6 (18.8)

20 (19.6)

5 (29.4)

0.589

Relaparotomy

49 (17.6)

8 (16.2)

18 (16.2)

6 (18.8)

17 (16.7)

4 (23.5)

0.744

Rejection episodes g

56 (20.1)

8 (24.2)

24 (21.6)

8 (25.0)

16 (15.7)

1 (5.9)

0.527

Delayed graft function h

26 (9.4)

1 (3.0)

11 (9.9)

2 (6.3)

12 (11.8)

0 (0)

0.447

Long-term surgical complications i (>90 days)

25 (9.0)

2 (6.1)

11 (9.9)

3 (9.4)

9 (8.8)

1 (5.9)

0.925

Mortality:

 (<30 days)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

 

 (<90 days)

1 (0.4)

0 (0)

1 (0.9)

0 (0)

0 (0)

0 (0)

 

Graft loss:

 (<30 days)

4 (1.4)

0 (0)

2 (1.8)

1 (3.1)

1 (1.0)

1 (5.9)

 

 (<90 days)

5 (1.8)

0 (0)

2 (1.8)

1 (3.1)

1 (1.0)

1 (5.9)

 

KT kidney transplantation, LDKT living donor kidney transplantation

* p-values are calculated for moon phases only.

avalues are number (percentage) unless indicated otherwise

bvalues are median [range]

cL = left, R = right, the first letter indicates the kidney, the second letter indicates the placement side

dincluding cardiac events, respiratory events, multiorgan failure and gastrointestinal bleeding

esome patients had more than one complication

fincluding vascular complications, ureteral complications, events of graft rupture and dislocation, developmant of lymphocele, peritonitis, postoperative hemorrhage, events of fascial dehiscence, superficial and deep wound infection

gall rejection episodes were biopsy-proven

hneed for dialysis in the first 7 days after transplant and/or the presence of biopsy-proven acute tubular necrosis (ATN)

iincluding vascular, urologic complications, fascial dehiscence, hernia

Fig. 3

Patient- and graft survival after living donor kidney transplantation (LDKT). Patient- and graft-survival rates at 1, 5, and 10 years after transplantation were 98.9, 92, and 88.7% and 97.4, 91.6, and 80.6%, respectively

Fig. 4

a Patient- and (b) graft survival after living donor kidney transplantation (LDKT) in recipients, grouped according to the four main moon phases: new moon (NM); waxing moon (WaxM); full moon (FM) and waning moon (WanM). The full moon phase, which, according to medical astrology, should be avoided for operations, did not show a worse course than other moon phases

Fig. 5

a Patient- and (b) graft survival after living donor kidney transplantation (LDKT) in recipients, grouped according to the moon sign Libra, which, according to medical astrology, is believed to interfere with surgical procedures of the kidneys and the urinary tract

Discussion

The present single center cohort study could reveal that timing of transplant surgery according to moon phases or the moon sign Libra generally had no measurable impact on short- and long-term outcome after living donor kidney transplantation.

Even in modern ‘informed’ societies, superstition still plays a significant role. Only a small proportion of people approach life in an entirely rational way [22]. Since superstition is in general often tied to unpredictable events beyond personal control, people may rely on astrology to predict the future. Even today, the concept of lunar phases influencing different aspects of daily life is very popular. The moon phase hypothesis, almost completely abandoned by the medical field since 1700 [23], had a renaissance in the second half of the 20th century after a report by Andrews in 1960 who observed an increased incidence of bleeding complications after tonsillectomies carried out during the full moon [8]. Studies in terms of an influence of the moon phases on human life thereafter were inconclusive [9, 10, 2434], or failed to confirm it [3538]. Nevertheless, several studies demonstrated significant differences in social life, for example in alcohol consumption, nutritional intake, birth rates, and the frequency of incidents such as crime, self-poisoning, suicide and traffic accidents, during the four moon phases [25, 3134]. Moreover, general practice consultation rates and hospital admissions for anxiety, depression, acute diarrhea, gastrointestinal bleeding, atrial fibrillation, myocardial infarction and cardiac arrest have been found to vary throughout the lunar cycle [9, 10, 24, 2630]. These reconfirmed a presumed dependence of social life and humans physical condition on a superordinate authority such as moon phases and moon signs. Accidents, violence, births rates and acute illnesses, however, can hardly be influenced or timely scheduled by humans. In the same sense, postoperative complications following transplantation in general occur by hazard. Therefore these results remain observantly. With regard to elective treatment, however, the question arises of how the physical condition of the doctor on one hand, and how the patients healing course on the other hand might be influenced by different phases of the moon. Furthermore, a specific timing of the treatment might improve the patient’s outcome. About 10.5% of the German population believes that particular moon phases influence disease onset, clinical course, and recovery. This number is even higher in the South of Germany where our transplant center is located. Here, up to 17.9% believe in the moon phase hypothesis [11]. In this context no clear scientific opinion on the influence of lunar phases on surgical outcome exists, and only few data is available to physicians and surgeons with which to relieve the patients’ concerns about wrong timing of surgery. Some studies have analyzed surgical outcome as a function of moon phases. Most of these studies could demonstrate no relationship between the lunar cycle and postoperative outcome after elective ambulantory surgery, surgery performed under general anesthesia, or more specific after breast cancer-, lung cancer-, bladder cancer- or ENT surgery [11, 3639].

The reason for the present study was due to an increasing patient demand for moon-phase-adjusted transplant appointments in our own department. Especially in transplantation medicine, the mental and psychological stress of all participants, especially donors and recipients is very high. Factors, such as the live organ of a closely related party, the threat of a life-threatening illness, the vague hope of cure but also the knowledge about the limited life-span of the new organ,put the patients under enormous pressure. All thinkable efforts are in general made in order to increase the likelihood of a perfect long term organ survival. Not surprisingly, our patient managers have to consult lunar calendars during the planning of LDKT appointments with increasing frequency. However, it is not always possible to accommodate the patients’ wish dates.

The present study has some limitations. First, it is a retrospective analysis of a single transplant center and the number of patients is limited. In addition, due to the retrospective design of our study, no randomization of the patients was realized.. However, a randomization of the patients would systematically ignore the patients preferences. Realization of such a randomized trial would therefore be challenging. As a consequence, we do not know in how many cases the transplant was scheduled according to the lunar phases on the explicit request of the patient. It would be interesting to know whether a strong desire of the patient and a corresponding fulfillment has any influence on the short- and long-term success of the surgery. It cannot be excluded that the patient’s fear of wrong timing of the transplantation might have a significant negative influence on postoperative recovery and outcome, irrespective of any influence of the moon.

However, the results of the present study revealed that the moon phases and the position of the moon in the moon sign Libra generally had no measurable impact on short- and long-term outcome after LDKT. These results are suitable to ease recipients, donors and relatives, if a transplantation procedure according to the moon cycle is not possible.

Conclusion

Our data indicate that there is no connection between moon phases, moon signs and results after living donor kidney transplantation (LDTK). On the other hand, physicians and surgeons should consider their patients’ preferences, wishes, and beliefs first. Therefore, patients who strongly confide in the impact of the moon phases on the outcome of surgery should be taken seriously and the correct timing of transplantation should be facilitated as long as it does not interfere with evidence-based treatment and center-specific regimens.

Notes

Abbreviations

FM: 

Full Moon

KT: 

Kidney transplantation

LDKT: 

Living Donor Kidney Transplantation

NM: 

New Moon

WanM: 

Waning Moon

WaxM: 

Waxing Moon

Declarations

Acknowledgements

We thank Dr. Cathleen McSharry for linguistic support of this manuscript.

Funding

No funding was received in relation to the present study.

Availability of data and materials

All data of this study is saved and stored by the first authors of this manuscript (A.K. and M.M). Insight into anonymized source data is possible, if intended.

Authors’ contributions

AK: idea, study concept, statistical analysis, manuscript writing. MM: database completion, statistical analysis, manuscript writing. PNK: discussion of results, manuscript writing assistance. SP, AK, MS, WDI, MKA: manuscript revision. KWJ: source data provision, discussion of results. MG: discussion of results, manuscript writing assistance. JW: discussion of results, manuscript revision. MR: data collection, manuscript writing, application of grant at committee of ethics, University of Munich. All authors have read and approved the manuscript.

Ethics approval and consent to participate

All patients undersigned the consent to use the routinely registered clinical data in an irreversibly anonymized fashion for scientific purposes. This approach was approved by the ethics committee of the University of Munich, (grant no. 17–151).

Consent for publication

Furthermore, for this long term retrospective analysis, no particular consent for publication is required, according to the committee’s suggestion.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of General-, Visceral-, Vascular- and Transplant Surgery, University of Munich

References

  1. Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol. 2005;16(7):2098–110.View ArticlePubMedGoogle Scholar
  2. Matas AJ, Payne WD, Sutherland DE, Humar A, Gruessner RW, Kandaswamy R, et al. 2,500 living donor kidney transplants: a single-center experience. Ann Surg. 2001;234(2):149–64.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Gill P, Lowes L. Gift exchange and organ donation: donor and recipient experiences of live related kidney transplantation. Int J Nurs Stud. 2008;45(11):1607–17.View ArticlePubMedGoogle Scholar
  4. de Groot IB, Schipper K, van Dijk S, van der Boog PJ, Stiggelbout AM, Baranski AG, et al. Decision making around living and deceased donor kidney transplantation: a qualitative study exploring the importance of expected relationship changes. BMC Nephrol. 2012;13:103.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Pradel FG, Mullins CD, Bartlett ST. Exploring donors’ and recipients’ attitudes about living donor kidney transplantation. Prog Transplant. 2003;13(3):203–10.View ArticlePubMedGoogle Scholar
  6. Waterman AD, Stanley SL, Covelli T, Hazel E, Hong BA, Brennan DC. Living donation decision making: recipients’ concerns and educational needs. Prog Transplant. 2006;16(1):17–23.View ArticlePubMedGoogle Scholar
  7. Eufrásio P, Parada B, Moreira P, Nunes P, Bollini S, Figueiredo A, Mota A. Surgical complications in 2000 renal transplants. Transplant Proc. 2011;43(1):142–4.View ArticlePubMedGoogle Scholar
  8. Andrews EJ. Moon talk: the cyclic periodicity of postoperative hemorrhage. J Fla Med Assoc. 1960;46:1362–6.PubMedGoogle Scholar
  9. Alves DW, Allegra JR, Cochrane DG, Cable G. Effect of lunar cycle on temporal variation in cardiopulmonary arrest in seven emergency departments during 11 years. Eur J Emerg Med. 2003;10(3):225–8.View ArticlePubMedGoogle Scholar
  10. Sha LR, Xu NT, Song XH, Zhang LP, Zhang Y. Lunar phases, myocardial infarction and hemorrheological character. A western medical study combined with appraisal of the related traditional chinese medical theory. Chin Med J. 1989;102(9):722–5.PubMedGoogle Scholar
  11. Holzheimer RG, Nitz C, Gresser U. Lunar phase does not influence surgical quality. Eur J Med Res. 2003;8(9):414–8.PubMedGoogle Scholar
  12. Paunegger Poppe J, Poppe T. Vom richtigen zeitpunkt die anwendung des mondkalenders im täglichen leben - ((button: Aktualisierte und erweiterte neuausgabe)). München: Heyne, W; 2015.Google Scholar
  13. Farrell RM, Stubenbord WT, Riggio RR, Muecke EC. Living renal donor. Nephrectomy: evaluation of 135 cases. J Urol. 1973;110(6):639–42.View ArticlePubMedGoogle Scholar
  14. Jacobs SC, McLaughlin AP, Halasz NH, Gittes RF. Live donor nephrectomy. Urology. 1975;5(2):175–7.View ArticlePubMedGoogle Scholar
  15. Switula D. Principles of good clinical practice (GCP) in clinical research. Sci Eng Ethics. 2000;6(1):71–7.View ArticlePubMedGoogle Scholar
  16. Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, et al. A checklist for retrospective database studies--report of the ISPOR task force on retrospective databases. Value Health. 2003;6(2):90–7.View ArticlePubMedGoogle Scholar
  17. (Online internet service of the texas mc donald observatory); Available from: http://stardate.org/nightsky/moon.
  18. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753–60.View ArticlePubMedGoogle Scholar
  19. Yarlagadda SG, Coca SG, Garg AX, Doshi M, Poggio E, Marcus RJ, Parikh CR. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant. 2008;23(9):2995–3003.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Neipp M, Jackobs S, Klempnauer J. Renal transplantation today. Langenbeck's Arch Surg. 2009;394(1):1–16.View ArticleGoogle Scholar
  21. Kleespies A, Mikhailov M, Khalil PN, Preissler G, Rentsch M, Arbogast H, et al. Enteric conversion after pancreatic transplantation: resolution of symptoms and long-term results. Clin Transpl. 2011;25(4):549–60.View ArticleGoogle Scholar
  22. Knowlton S. Health guidance; Available from: http://www.healthguidance.org/entry/15659/1/How-to-stop-being-Superstitious. Accessed 2013.
  23. Harrison M. From medical astrology to medical astronomy: sol-lunar and planetary theories of disease in british medicine, c. 1700–1850. Br J Hist Sci. 2000;33(116 Pt 1):25–48.View ArticlePubMedGoogle Scholar
  24. Mikulecky M, Ondrejka P. Moon cycle and acute diarrheal infections in bratislava 1988–1990. In: Gutenbrunner C, Hildebrandt G, Moog R, editors. Chronobiology and Chronomedicine. Frankfurt, Berlin, Bern, New York, Paris, Wien: P. Lang; 1993. p. 356–60.Google Scholar
  25. Buckley NA, Whyte IM, Dawson AH. There are days … and moons. Self-poisoning is not lunacy. Med J Aust. 1993;159(11–12):786–9.PubMedGoogle Scholar
  26. Wilkinson G, Piccinelli M, Roberts S, Micciolo R, Fry J. Lunar cycle and consultations for anxiety and depression in general practice. Int J Soc Psychiatry. 1997;43(1):29–34.View ArticlePubMedGoogle Scholar
  27. de Castro JM, Pearcey SM. Lunar rhythms of the meal and alcohol intake of humans. Physiol Behav. 1995;57(3):439–44.View ArticlePubMedGoogle Scholar
  28. Mikulecky M, Valachova A. Lunar influence on atrial fibrillation? Braz J Med Biol Res. 1996;29(8):1073–5.PubMedGoogle Scholar
  29. Román EM, Soriano G, Fuentes M, Gálvez ML, Fernández C. The influence of the full moon on the number of admissions related to gastrointestinal bleeding. Int J Nurs Pract. 2004;10(6):292–6.View ArticlePubMedGoogle Scholar
  30. Neal RD, Colledge M. The effect of the full moon on general practice consultation rates. Fam Pract. 2000;17(6):472–4.View ArticlePubMedGoogle Scholar
  31. Ghiandoni G, Seclì R, Rocchi MB, Ugolini G. Does lunar position influence the time of delivery? A statistical analysis. Eur J Obstet Gynecol Reprod Biol. 1998;77(1):47–50.View ArticlePubMedGoogle Scholar
  32. Thakur CP, Sharma D. Full moon and crime. Br Med J (Clin Res Ed). 1984;289(6460):1789–91.View ArticleGoogle Scholar
  33. Jones PK, Jones SL. Lunar association with suicide. Suicide Life Threat Behav. 1977;7(1):31–9.PubMedGoogle Scholar
  34. Alonso Y. Geophysical variables and behavior: LXXII. Barometric pressure, lunar cycle, and traffic accidents. Percept Mot Skills. 1993;77(2):371–6.View ArticlePubMedGoogle Scholar
  35. Smolle J, Prause G, Kerl H. A double-blind, controlled clinical trial of homeopathy and an analysis of lunar phases and postoperative outcome. Arch Dermatol. 1998;134(11):1368–70.View ArticlePubMedGoogle Scholar
  36. May M, Braun KP, Helke C, Richter W, Vogler H, Hoschke B, Siegsmund M. Lunar phases and zodiac signs do not influence quality of radical cystectomy--a statistical analysis of 452 patients with invasive bladder cancer. Int Urol Nephrol. 2007;39(4):1023–30.View ArticlePubMedGoogle Scholar
  37. Kuehnl A, Herzog M, Schmidt M, Hornung HM, Jauch KW, Hatz RA, Graeb C. The dark side of the moon: impact of moon phases on long-term survival, mortality and morbidity of surgery for lung cancer. Eur J Med Res. 2009;14(4):178–81.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Peters-Engl C, Frank W, Kerschbaum F, Denison U, Medl M, Sevelda P. Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases. Breast Cancer Res Treat. 2001;70(2):131–5.View ArticlePubMedGoogle Scholar
  39. Kumar VV, Kumar NV, Isaacson G. Superstition and post-tonsillectomy hemorrhage. Laryngoscope. 2004;114(11):2031–3.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement